As an Australian-headquartered venture capital firm with a growing UK presence, the BIA has been instrumental in helping me raise awareness of Brandon Capital and create opportunities for our portfolio companies across the UK biotech ecosystem.

An invaluable partner in amplifying our presence in the UK and beyond, the BIA’s excellent networking events, insightful policy papers, and strong communication channels have helped us connect with key industry stakeholders and stay ahead of policy developments.

We actively encourage our portfolio companies, including those headquartered in Australia, to join as they expand into the UK, as BIA membership offers immediate access to a trusted, internationally connected community and enhances visibility across the life sciences sector.

We also value the BIA’s close partnership with the government and its influence on shaping policy.

Dr Jonathan Tobin

Partner, Brandon Capital UK

The BIA is a truly exceptional organisation, bringing together companies across the life sciences ecosystem, from Biotech and TechBio to biopharma, big and small. For companies like Relation, being part of this community is invaluable. The BIA not only fosters connection through networking and community events, but also plays a critical role in shaping policy, supporting leadership development, and championing innovation across the UK. We’re proud to be members of such a vibrant and mission-driven network, thank you for all that you do!

Rosie Rodriguez PhD

SVP Growth, Relation Therapeutics

The Wellcome Sanger Institute is proud to be an active member of the BIA. The BIA’s commitment to driving innovation aligns with the Sanger Institute mission. Through the BIA network of like-minded organisations we can expand the reach and impact of Sanger’s science at scale.

Dr Julia Wilson

Director of Strategy, Partnerships and Innovation, Wellcome Sanger Institute

Joining the BIA was an easy decision for Stablepharma, not only to participate in their excellent networking events but also to be part of an organisation that has the focus and lobbying power with relevant government bodies in the UK. It is always good to meet other technology and biotechnology companies within the life sciences space, as well as suppliers and specialists in our industry sector. BIA’s clear commitment to progressing and celebrating the successes of the UK life sciences sector for ultimately, better patient and population healthcare, is truly impressive.

Ozgur Tuncer

CEO and Executive Director, Stablepharma

The BIA is simply the best trade organisation I've been a member of in 40 years of business, well done BIA!

Nick Child

Co-Founder & VP, Stablepharma

Thanks for sending through this [mRNA report] - really interesting and useful piece of work. These sorts of maps and analysis of what we have (and what we don’t have) will be very helpful. As you know, they certainly were during Covid.

Patrick Vallance

UK Minister for Science, Research and Innovation

We’re honoured to be named the BioIndustry Association’s Charity Partner for 2025. This partnership will help us address the disparities in blood cancer outcomes across the UK. We have been working closely with the industry for the last decade, and now with the BIA's support, we will amplify our work to improve survival rates and strive to ensure that no one’s chances of survival are determined by where they live.

Together, we can drive vital change and ensure the UK is a global leader when it comes to blood cancer survival.

Helen Rowntree

CEO of Blood Cancer UK